News tagged with melanomas
SLAC X-rays help discover new drug against melanoma
It was front page news around the world: a drug designed to disrupt malignant melanoma, the deadliest form of skin cancer, was so successful in its latest round of testing in humans that the tests were halted & ...
Chemistry / Analytical Chemistry
Jul 19, 2011 |
5 / 5 (2) |
0
Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Nanotechnology / Bio & Medicine
Jun 13, 2011 |
5 / 5 (5) |
1
|
Bristol-Myers pitches its cancer medicine pipeline
(AP) -- Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.
Jun 06, 2011 |
not rated yet |
0
Studies find new drugs boost skin cancer survival
(AP) -- They're not cures, but two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors reported Sunday.
Jun 06, 2011 |
not rated yet |
0
Novel microscope could be used for melanoma detection
Suspicion of melanoma: In the future, doctors can pull out a new type of microscope to get to the bottom of suspicious changes in the skin. It provides a high-resolution image of skin areas of any size – ...
May 10, 2011 |
5 / 5 (1) |
0
Modern targeted drug plus old malaria pill serve a 1-2 punch in advanced cancer patients
Researchers at the University of Pennsylvania School of Medicine may have found a way to turn an adaptive cellular response into a liability for cancer cells. When normal cells are starved for food, they chew up existing ...
Apr 05, 2011 |
4 / 5 (1) |
1
Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity
The combination of two compounds that inhibit two of the most frequently mutated cancer pathways is showing promise in an ongoing Phase I trial, according to data presented at the AACR 102nd Annual Meeting 2011, held here ...
Apr 02, 2011 |
not rated yet |
0
Researchers publish molecular disease model for melanoma
Cancer Commons, an initiative of CollabRx, a provider of information technology to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model of melanoma (MDMM) which classifies ...
Mar 30, 2011 |
not rated yet |
0
Viral replicase points to potential cancer therapy
Alpha viruses, such as Sindbis virus, carry their genetic information on a single strand of RNA. On infection they use a protein, replicase, to produce double stranded RNA (dsRNA) which is used as genetic material to make ...
Mar 28, 2011 |
not rated yet |
0
FDA approves new drug for advanced melanoma
The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma is more than a decade.
Mar 25, 2011 |
not rated yet |
0
FDA clears first melanoma drug to extend life
(AP) -- The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with ...
Medicine & Health / Medications
Mar 25, 2011 |
4.3 / 5 (4) |
1
Arthritis drug could help beat melanoma skin cancer
A breakthrough discovery by the University of East Anglia (UEA) and Children's Hospital Boston promises an effective new treatment for one of the deadliest forms of cancer.
Mar 23, 2011 |
4.8 / 5 (4) |
5
|
Melanoma diagnosis in women associated with higher socioeconomic status
The incidence of melanoma appears higher in non-Hispanic white adolescent girls and young women living in higher socioeconomic neighborhoods than those living in lower socioeconomic areas, according to a report posted online ...
Mar 21, 2011 |
not rated yet |
0
Researchers discover possible biomarker and therapeutic target for melanoma
Researchers at Boston University School of Medicine (BUSM), in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma. The novel cell screening method used ...
Mar 17, 2011 |
not rated yet |
0
Scientists create new cell lines from ocular melanoma patients
Researchers at UCLA's Jules Stein Eye Institute have created new tumor cell lines from fine-needle biopsies of ocular melanoma patients who had undergone treatment but died when their cancer spread aggressively.
Mar 11, 2011 |
not rated yet |
0
Melanoma
Melanoma i/ˌmɛləˈnoʊmə/ (from Greek μέλας - melas, "dark") is a malignant tumor of melanocytes. Melanocytes are cells that produce the dark pigment, melanin, which is responsible for the color of skin. They predominantly occur in skin, but are also found in other parts of the body, including the bowel and the eye (see uveal melanoma). Melanoma can occur in any part of the body that contains melanocytes.
Melanoma is less common than other skin cancers. However, it is much more dangerous and causes the majority (75%) of deaths related to skin cancer. Worldwide, doctors diagnose about 160,000 new cases of melanoma yearly. The diagnosis is more frequent in women than in men and is particularly common among Caucasians living in sunny climates, with high rates of incidence in Australia, New Zealand, North America, Latin America, and northern Europe. According to a WHO report, about 48,000 melanoma related deaths occur worldwide per year.
The treatment includes surgical removal of the tumor, adjuvant treatment, chemo- and immunotherapy, or radiation therapy. The chance of a cure is greatest when the tumor is discovered while it is still small and thin, and can be entirely removed surgically.
For more information about Melanoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
